GS0351: Business development services, namely, assistance in product commercialization for third parties of pharmaceuticals and substances for the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancer, and infectious diseases
GS0421: Production, namely, pharmaceutical product and drug development; Drug discovery and research, and development of pharmaceuticals and substances in the nature of polypeptides, particularly antibodies and antibody derivatives, for the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancer, and infectious diseases; Drug discovery and research and development in the pharmaceutical and biotechnology fields; Research, development, engineering and testing services in the fields of pharmaceutical and biotechnology products; Providing medical and scientific research information in the field of pharmaceuticals and biotechnology
Case File Event Statements
12/30/2015 - 10 years ago
15 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILEDType:NONP
12/14/2015 - 10 years ago
14 - APPROVED FOR PUB - PRINCIPAL REGISTERType:CNSA
12/14/2015 - 10 years ago
13 - EXAMINER'S AMENDMENT ENTEREDType:XAEC
12/14/2015 - 10 years ago
12 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILEDType:GNEN
12/14/2015 - 10 years ago
11 - EXAMINERS AMENDMENT E-MAILEDType:GNEA
12/14/2015 - 10 years ago
10 - EXAMINERS AMENDMENT -WRITTENType:CNEA
12/11/2015 - 10 years ago
9 - TEAS/EMAIL CORRESPONDENCE ENTEREDType:TEME
12/10/2015 - 10 years ago
8 - CORRESPONDENCE RECEIVED IN LAW OFFICEType:CRFA
12/10/2015 - 10 years ago
7 - TEAS RESPONSE TO OFFICE ACTION RECEIVEDType:TROA
8/10/2015 - 10 years ago
6 - NOTIFICATION OF NON-FINAL ACTION E-MAILEDType:GNRN
8/10/2015 - 10 years ago
5 - NON-FINAL ACTION E-MAILEDType:GNRT
8/10/2015 - 10 years ago
4 - NON-FINAL ACTION WRITTENType:CNRT
8/4/2015 - 10 years ago
3 - ASSIGNED TO EXAMINERType:DOCK
5/5/2015 - 10 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAMType:NWOS